Chen, Xiangqi
Zhou, Zixiang
Li, Shuofeng
Yu, Guanhua
Feng, Shi
Zhou, Ze
Sun, Boyu
Wang, Shanshan
Liu, Kai
Li, Chengjie
Piao, Mingjian
Wang, Mingming
Zhang, Yihong
Li, Hu
Zhu, Chengpei
Zhu, Zhenyu
Zhao, Haitao
Article History
Received: 7 August 2025
Accepted: 12 September 2025
First Online: 29 September 2025
Declarations
:
: The authors declare no competing interests.
: This study was performed in accordance with the Declaration of Helsinki, and it was approved by the Institutional Review Board of PUMCH (No. I-24PJ2728, I-24PJ2730, and I-25PJ0158) and PLAGH (No. KY-2025–1-18–1). All patients provided written informed consent before receiving ICI–chemotherapy combination and relevant target/LRTs.